T helper 1, 2 and 17 cell subsets in renal transplant patients with delayed graft function

Transplant International

Volumn 24, Issue 3, 2011, Pages 233-242

  Loverre, Antonia ^a   Divella, Chiara ^a   Castellano, Giuseppe ^a   Tataranni, Tiziana ^a   Zaza, Gianluigi ^a   Rossini, Michele ^a   Ditonno, Pasquale ^a   Battaglia, Michele ^a   Palazzo, Silvano ^a   Gigante, Margherita ^b   Ranieri, Elena ^b   Schena, Francesco Paolo ^a   Grandaliano, Giuseppe ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

adaptive immunity; delayed graft function; ischemia reperfusion; kidney transplantation; T cells

Indexed keywords

CALCINEURIN INHIBITOR; CD20 ANTIGEN; CD4 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET;

ACUTE GRAFT REJECTION; ADAPTIVE IMMUNITY; ADULT; ARTICLE; CLINICAL FEATURE; CONFOCAL LASER MICROSCOPY; CYTOFLUOROMETRY; CYTOKINE RELEASE; DELAYED GRAFT FUNCTION; DEMOGRAPHY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; ISCHEMIA; KIDNEY TRANSPLANTATION; KIDNEY TUBULE DAMAGE; MAJOR CLINICAL STUDY; NEPHROTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; TH1 CELL; TH17 CELL; TH2 CELL;

ADULT; ANIMALS; COLD ISCHEMIA; DELAYED GRAFT FUNCTION; GRAFT REJECTION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-4; KIDNEY TRANSPLANTATION; MIDDLE AGED; REPERFUSION INJURY; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TH2 CELLS;

EID: 79551541633     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2010.01157.x     Document Type: Article

References (43)

1. Quiroga I, McShane P, Koo DD, et al. Major effects of delayed graft function and cold ischemia time on renal allograft survival. Nephrol Dial Transplant 2006; 21: 1689.
2. Hetzel GR, Klein B, Brause M, et al. Risk factors for delayed graft function after renal transplantation and their significance for long-term clinical outcome. Transplant Int 2002; 15: 10.
3. Perico N, Cattaneo D, Sayegh MH, et al. Delayed graft function in kidney transplantation. Lancet 2004; 364: 1814.
4. Loverre A, Ditonno P, Crovace A, et al. Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: differential modulation by rapamycin. J Am Soc Nephrol 2004; 15: 2675.
5. Boros P, Bromberg JS,. New cellular and molecular immune pathways in ischemia/reperfusion injury. Am J Transplant 2006; 6: 652.
6. Gaber LW, Gaber AO, Hathaway DK, et al. Routine early biopsy of allografts with delayed graft function: correlation of histopathology and transplant outcome. Clin Transplant 1996; 10: 629.
7. Andrade CF, Waddell TK, Keshavjee S, et al. Innate immunity and organ transplantation: the potential role of toll-like receptors. Am J Transplant 2005; 5: 969.
8. Loverre A, Capobianco C, Stallone G, et al. Ischemia-reperfusion injury-induced abnormal dendritic cell traffic in the transplanted kidney with delayed graft function. Kidney Int 2007; 72: 994.
9. Ysebaert DK, De Greef KE, Vercauteren SR, et al. Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol Dial Transplant 2000; 10: 1562.
10. Rabb H, Daniels F, O'Donnell M, et al. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol 2000; 279: F525.
11. Burne MJ, Daniels F, El Ghandour A, et al. Identification of the CD4+ T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 2001; 108: 1283.
12. Yokota N, Daniels F, Crosson J, et al. Protective effect of T cell depletion in murine renal ischemia-reperfusion injury. Transplantation 2002; 74: 759.
13. Burne-Taney MJ, Ascon DB, Daniels F, Racusen L, Baldwin W, Rabb H., B cell deficiency confers protection from renal ischemia reperfusion injury. J Immunol 2003; 171: 3210.
14. Nikbakht-Sangari M, Qayumi AK, Keown PA,. The role of inflammatory mediators in the mechanism of the host immune response induced by ischemia-reperfusion injury. Immunol Invest 2000; 29: 13.
15. + T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest 1997; 100: 279.
16. Rabb H,. The T cell as a bridge between innate and adaptive immune systems: implications for the kidney. Kidney Int 2002; 61: 1935.
17. Huang Y, Rabb H, Womer KL,. Ischemia-reperfusion and immediate T cell responses. Cell Immunol 2007; 248: 4.
18. Miossec P, Korn T, Kuchroo VK,. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009; 361: 888.
19. Szabo SJ, Sullivan BM, Stemmann C, et al. Distinct effects of T-bet in Th1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 2002; 295: 338.
20. Dardalhon V, Korn T, Kuchroo VK, Anderson AC,. Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun 2008; 31: 252.
21. Afzali B, Lombardi G, Lechler RI, et al. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007; 148: 32.
22. Chan RW, Lai FM, Li EK, et al. Imbalance of Th1/Th2 transcription factors in patients with lupus nephritis. Rheumatology 2006; 45: 951.
23. Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006; 126: 1121.
24. Aggarwal S, Ghilardi N, Xie MH, et al. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003; 278: 1910.
25. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6: 1123.
26. Loong CC, Hsieh HG, Lui WY, et al. Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection. J Pathol 2002; 197: 322.
27. Tang JL, Subbotin VM, Antonysamy MA, et al. Interleukin-17 antagonism inhibits acute but not chronic vascular rejection. Transplantation 2001; 72: 348.
28. Li J, Simeoni E, Fleury S, et al. Gene transfer of soluble interleukin-17 receptor prolongs cardiac allograft survival in a rat model. Eur J Cardiothorac Surg 2006; 29: 779.
29. Yuan X, Paez-Cortez J, Schmitt-Knosalla I, et al. A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J Exp Med 2008; 205: 3133.
30. Mao Q, Terasaki PI, Cai J, et al. Analysis of HLA class I specific antibodies in patients with failed allografts. Transplantation 2007; 83: 54.
31. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8: 753.
32. Humar A, Payne WD, Sutherland DE, et al. Clinical determinants of multiple acute rejection episodes in kidney transplant Recipients. Transplantation 2000; 69: 2357.
33. Boom H, Mallat MJ, de Fijter JW, et al. Delayed graft function influences renal function, but not survival. Kidney Int 2000; 58: 859.
34. Kim BS, Lim SW, Li C, et al. Ischemia-reperfusion injury activates innate immunity in rat kidneys. Transplantation 2005; 79: 1370.
35. Ascon DB, Lopez-Briones S, Liu M, et al. Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury. J Immunol 2006; 177: 3380.
36. Ysebaert DK, De Greef KE, De Beuf A, et al. T cells as mediators in renal ischemia/reperfusion injury. Kidney Int 2004; 66: 491.
37. D'Elios MM, Josien R, Manghetti M, et al. Predominant Th1 cell infiltration in acute rejection episodes of human kidney grafts. Kidney Int 1997; 51: 1876.
38. Yokota N, Burne-Taney M, Racusen L, et al. Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 2003; 285: F319.
39. Van Kooten C, Boonstra JG, Paape ME, et al. Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. J Am Soc Nephrol 1998; 9: 1526.
40. Yuan X, Paez-Cortez J, Schmitt-Knosalla I, et al. A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J Exp Med 2008; 13: 3133.
41. + Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient mice. J Immunol 2008; 181: 3906.
42. Yuan X, Ansari MJ, D'Addio F, et al. Targeting Tim-1 to overcome resistance to transplantation tolerance mediated by CD8 T17 cells. Proc Natl Acad Sci USA 2009; 106: 10734.
43. Murphy KM, Stockinger B,. Effector T cell plasticity: flexibility in the face of changing circumstances. Nat Immunol 2010; 11: 674.